Group One Trading
SCMP

Group One Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Group One Trading’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-246,600
Closed -$4.43M – 5696
2017
Q4 		$4.43M Buy
246,600
+245,300
+18,869% +$3.02M 0.03% 697
2017
Q3 		$15K Sell
1,300
-68,000
-98% -$763K ﹤0.01% 4184
2017
Q2 		$728K Buy
69,300
+40,400
+140% +$412K 0.01% 1696
2017
Q1 		$318K Buy
28,900
+19,100
+195% +$222K ﹤0.01% 2194
2016
Q4 		$133K Buy
9,800
+6,500
+197% +$90.7K ﹤0.01% 2686
2016
Q3 		$41K Sell
3,300
-1,800
-35% -$21.2K ﹤0.01% 3457
2016
Q2 		$56K Buy
5,100
+3,300
+183% +$36.9K ﹤0.01% 3246
2016
Q1 		$20K Sell
1,800
-2,200
-55% -$27.8K ﹤0.01% 3757
2015
Q4 		$69K Sell
4,000
-28,200
-88% -$506K ﹤0.01% 3227
2015
Q3 		$640K Buy
32,200
+27,500
+585% +$630K 0.01% 1582
2015
Q2 		$77K Sell
4,700
-10,300
-69% -$179K ﹤0.01% 3267
2015
Q1 		$233K Sell
15,000
-20,700
-58% -$321K ﹤0.01% 2253
2014
Q4 		$510K Buy
+35,700
New +$377K 0.01% 1549
2014
Q3 		– Sell
-200
Closed -$1K – 5662
2014
Q2 		$1K Hold
200
– – ﹤0.01% 5083
2014
Q1 		$1K Sell
200
-500
-71% -$4.28K ﹤0.01% 5096
2013
Q4 		$7K Buy
+700
New +$4.99K ﹤0.01% 4761
2013
Q3 		– Sell
-2,800
Closed -$18K – 5844
2013
Q2 		$18K Buy
+2,800
New +$22.2K ﹤0.01% 4144

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Group One Trading's SCMP Position: Q1 2018 in Review

Group One Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 27,735 shares — an estimated $498K sold.

Group One Trading first reported a position in SCMP in Q3 2013 and held it in 6 quarters. The position peaked at $498K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Group One Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Group One Trading sold 27,735 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $498K.
  • Group One Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
  • Group One Trading's Sucampo Pharmaceuticals, Inc. position peaked at $498K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.